Colistin-induced structural and biochemical changes in carbapenem-resistant Acinetobacter baumannii isolated from the hospital environment.

[1]  J. Madec,et al.  Healthcare Equipment and Personnel Reservoirs of Carbapenem-Resistant Acinetobacter baumannii Epidemic Clones in Intensive Care Units in a Tunisian Hospital , 2023, Microorganisms.

[2]  W. van Schaik,et al.  Endemicity and diversification of carbapenem-resistant Acinetobacter baumannii in an intensive care unit , 2023, The Lancet regional health. Western Pacific.

[3]  Chienhsiu Huang,et al.  Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis , 2022, Journal of clinical medicine.

[4]  O. Ergonul,et al.  Elimination of healthcare associated Acinetobacter baumannii infection in a highly endemic region. , 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[5]  D. Álvarez-Hernández,et al.  Acinetobacter baumannii Resistance: A Real Challenge for Clinicians , 2020, Antibiotics.

[6]  X. Xue,et al.  Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection , 2020, Journal of Biomedical Science.

[7]  T. O. Ajiboye.  Contributions of reactive oxygen species, oxidative DNA damage and glutathione depletion to the sensitivity of Acinetobacter baumannii to 2-(2-nitrovinyl) furan. , 2019, Microbial pathogenesis.

[8]  R. Greer,et al.  Misidentification of Burkholderia pseudomallei as Acinetobacter species in northern Thailand , 2018, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[9]  Prince Sharma,et al.  Curcumin alleviates persistence of Acinetobacter baumannii against colistin , 2018, Scientific Reports.

[10]  T. Chakraborty,et al.  Predictors of the extended-spectrum-beta lactamases producing Enterobacteriaceae neonatal sepsis at a tertiary hospital, Tanzania , 2018, International journal of medical microbiology : IJMM.

[11]  S. Lévêque-Fort,et al.  Impact of Bacterial Membrane Fatty Acid Composition on the Failure of Daptomycin To Kill Staphylococcus aureus , 2018, Antimicrobial Agents and Chemotherapy.

[12]  A. Hassanzadeh,et al.  Detection of antibiotic resistant Acinetobacter baumannii in various hospital environments: potential sources for transmission of Acinetobacter infections , 2017, Environmental Health and Preventive Medicine.

[13]  Ya-ping Pan,et al.  The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis , 2017, Annals of Clinical Microbiology and Antimicrobials.

[14]  M. Vaneechoutte,et al.  Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound Center , 2016, PloS one.

[15]  Jiayu Chen,et al.  Characterization of bla(OxA-23) gene regions in isolates of Acinetobacter baumannii. , 2015, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[16]  Yonghong Xiao,et al.  Bacterial-resistance among outpatients of county hospitals in China: significant geographic distinctions and minor differences between central cities. , 2015, Microbes and infection.

[17]  B. Liu,et al.  Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii. , 2014, Revista da Sociedade Brasileira de Medicina Tropical.

[18]  D. Warren,et al.  Effectiveness of infection prevention measures featuring advanced source control and environmental cleaning to limit transmission of extremely-drug resistant Acinetobacter baumannii in a Thai intensive care unit: An analysis before and after extensive flooding. , 2014, American journal of infection control.

[19]  D. Kwon,et al.  Promoter deletions of Klebsiella pneumoniae carbapenemase (KPC)-encoding genes (blaKPC -2) and efflux pump (AcrAB) on β-lactam susceptibility in KPC-producing Enterobacteriaceae. , 2013, FEMS microbiology letters.

[20]  Wonkeun Song,et al.  Increasing prevalence of blaOXA-23-carrying Acinetobacter baumannii and the emergence of blaOXA-182-carrying Acinetobacter nosocomialis in Korea. , 2013, Diagnostic microbiology and infectious disease.

[21]  C. Zimring,et al.  The Role of the Hospital Environment in the Prevention of Healthcare-Associated Infections by Contact Transmission , 2013 .

[22]  S. Maloney,et al.  Acinetobacter bacteraemia in Thailand: evidence for infections outside the hospital setting , 2013, Epidemiology and Infection.

[23]  J. Vila,et al.  Contribution of Efflux Pumps, Porins, and β-Lactamases to Multidrug Resistance in Clinical Isolates of Acinetobacter baumannii , 2013, Antimicrobial Agents and Chemotherapy.

[24]  B. Khanal,et al.  Acinetobacter Species: Phenotypic Characterization And Antimicrobial Resistance , 2013 .

[25]  M. Adams,et al.  The Success of Acinetobacter Species; Genetic, Metabolic and Virulence Attributes , 2012, PloS one.

[26]  L. Arend,et al.  Surveillance programme for multidrug-resistant bacteria in healthcare-associated infections: an urban perspective in South Brazil. , 2012, The Journal of hospital infection.

[27]  E. Y. Kim,et al.  Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit , 2010, BMC infectious diseases.

[28]  G. Snyder,et al.  Frequent Multidrug-Resistant Acinetobacter baumannii Contamination of Gloves, Gowns, and Hands of Healthcare Workers , 2010, Infection Control & Hospital Epidemiology.

[29]  G. Di Bonaventura,et al.  Misidentification of ampicillin-sulbactam heteroresistance in Acinetobacter baumannii strains from ICU patients. , 2009, The Journal of infection.

[30]  G. Funke,et al.  Evaluation of the New VITEK 2 Card for Identification of Clinically Relevant Gram-Negative Rods , 2004, Journal of Clinical Microbiology.

[31]  P. Nordmann,et al.  Acquired carbapenem-hydrolyzing beta-lactamases and their genetic support. , 2002, Current pharmaceutical biotechnology.

[32]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[33]  G. L. Miller.  Use of Dinitrosalicylic Acid Reagent for Determination of Reducing Sugar , 1959 .

[34]  OUP accepted manuscript , 2021, FEMS Microbiology Letters.

[35]  Woo-In Lee,et al.  Misidentification of Acinetobacter baumannii as Alcaligenes faecalis by VITEK 2 System; Case Report. , 2017, Laboratory medicine.